Platelet Transfusion Clinical Trial
Official title:
Cold Apheresis Platelets in PAS
This is a platelet transfusion study. The purpose of this study is to measure the life span and quality of platelets stored in a refrigerator. Participants will give platelets by apheresis. Platelets will be stored for 3 -20 days. A small portion of the subject's own stored platelets will be tagged with a radioactive isotope and infused back into the participant. This will enable us to track how many transfused platelets survive after storage in the refrigerator.
A single hyperconcentrated apheresis platelet unit will be collected from a healthy adult
volunteer subject using the Trima Accel® Automated Blood Collection System. Concurrent plasma
will be collected. The platelet unit will be stored, not-agitated, for up to 20 days at 4°C
in a suspension of 35% plasma and 65% PAS (Platelet Additive Solution).
At the end of the storage period, the subject will return to receive an 111Indium Oxine
(Indium 111, In-111) radiolabeled aliquot of their 4°C stored platelets. Follow-up samples
from the subject will be collected approximately 2 hours post-infusion and on Days 1 (2X), 2
(2X), and 3 to calculate recovery and survival of the subject's 4°C stored platelets. The Day
1 and Day 2 the sample draws will be 2 - 10 hours apart.
In addition to radiolabeled platelet recovery and survival measurements, various in vitro
assays will be performed on the day of collection at the end of 4°C storage.
One week after the infusion of the radiolabeled aliquot, the subject will return to receive a
second radiolabeled aliquot of fresh platelets. To facilitate this, on the morning of the
second infusion, the subject will return for collection of a 43 mL blood sample. The blood
will be processed to obtain a fresh sample of the subject's platelets to serve as a control
comparator. The platelets will be radiolabeled with In-111. The subject will return later in
the day for infusion of the radiolabeled fresh 'control' comparator aliquot. Follow-up blood
samples will be drawn at ~2 hours after the infusion on Day 0 and then on Days 1, 2, 3, 4 or
5, and 6 or 7 day post infusion to calculate recovery and survival of the subject's fresh vs.
stored platelets.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06043050 -
PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia (PROSPECT)
|
||
Completed |
NCT03110887 -
Monitoring Outcome in Neonatal Thrombocytopenia
|
N/A | |
Recruiting |
NCT03325140 -
Platelet Transfusions in Critically Ill Patient
|
||
Completed |
NCT03814486 -
Retrospective Descriptive Study of Platelet Transfusion in Patients With Palliative Hematologic Malignancies at the University Hospital of Besançon
|
||
Recruiting |
NCT03505086 -
Bleeding In Thrombocytopenia Explained
|
||
Completed |
NCT03045068 -
Platelet Transfusion During Neonatal Open Heart Surgery
|
Phase 4 | |
Completed |
NCT03806712 -
Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)
|